"The European Commission is pressing ahead with a plan to cut the number of years of market exclusivity — the period before a drugmaker faces competition from generic manufacturers — from 10 to eight years, despite fierce opposition from the industry and concerns from larger countries that have greater access to medicines."

https://www.ft.com/content/ace93ce5-7baa-41c5-9f6b-2a01e64914e4